Skip to content

Company

Paradigm Pharmaceuticals (United States)

New York, United States · paradigmpharma.com

Manage this page

Citations, last 5 years: 1
Works, last 5 years: 8
h-index: 23
Scientists listed: 1
Grants since 2016: 5

Grants received

2022 · grant · Standard Grant

SBIR Phase I: A Non-thermal Plasma Reactor System for Destruction of Particulate Matter in High-Temperature Diesel Exhaust

Vince Pilletteri · Paradigm Pharmaceuticals (United States) · funded by National Science Foundation

$256kAerosol Filtration and Electrostatic Precipitation

2018–2019 · research · R41

Dual Tack Mesh Fixation System: Creation of a Mesh Fixation System for Hernia Treatment and Prevention

John Patrick Fischer · Paradigm Pharmaceuticals (United States) · funded by National Institutes of Health

$224.9kHernia repair and management

2017–2018 · research · R41

Development and Validation of SafeClose Mesh Augmentation System for Hernia Prevention

John Patrick Fischer · Paradigm Pharmaceuticals (United States) · funded by National Institutes of Health

$243.1k

2017–2022 · research · R44

Paradigm Surgical Phase II-Development and Validation of SafeClose Roller Mesh Augmentation System for Hernia Treatment and Prevention

John Patrick Fischer · Paradigm Pharmaceuticals (United States) · funded by National Institutes of Health

$1MHernia repair and management

2017–2022 · research · R44

Paradigm Surgical Phase II-Development and Validation of SafeClose Roller Mesh Augmentation System for Hernia Treatment and Prevention

John Patrick Fischer · Paradigm Pharmaceuticals (United States) · funded by National Institutes of Health

$473.5kHernia repair and management